Scottsdale, AZ, United States of America

Melha Mellata


Average Co-Inventor Count = 1.7

ph-index = 2

Forward Citations = 29(Granted Patents)


Location History:

  • Tempe, AZ (US) (2013)
  • Scottsdale, AZ (US) (2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Melha Mellata: Innovator in Recombinant Bacterium Technology

Introduction

Melha Mellata is a prominent inventor based in Scottsdale, AZ (US). She has made significant contributions to the field of biotechnology, particularly in the development of recombinant bacteria for vaccine applications. With a total of 2 patents, her work focuses on enhancing immune responses against enteric pathogens.

Latest Patents

Mellata's latest patents include innovative technologies that utilize recombinant bacteria. The first patent, titled "Recombinant bacterium comprising a toxin/antitoxin system," describes a recombinant bacterium suitable for live attenuated vaccines. This invention encompasses a bacterium that includes a first promoter linked to a nucleic acid encoding a toxin and a second promoter linked to a nucleic acid encoding an antitoxin, with the second promoter being inactive in vivo but active in vitro. The second patent, "Recombinant bacterium capable of eliciting an immune response against enteric pathogens," relates to a recombinant bacterium that can elicit an immune response against at least two enteric pathogens without significantly inducing an immune response specific to the serotype of the bacterium. This invention also includes methods for making such a bacterium and its applications in vaccines.

Career Highlights

Melha Mellata is affiliated with Arizona State University, where she conducts her research and development work. Her innovative approaches in biotechnology have positioned her as a key figure in the field, contributing to advancements in vaccine technology.

Collaborations

Mellata has collaborated with notable colleagues, including Roy Curtiss III and Bereket Zekarias. These collaborations have further enhanced her research and the impact of her inventions in the scientific community.

Conclusion

Melha Mellata's work in recombinant bacterium technology exemplifies her commitment to advancing vaccine development. Her patents reflect her innovative spirit and dedication to improving public health through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…